Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
*Psorospermum febrifugum* extract is a botanical therapeutic derived from the African medicinal shrub *Psorospermum febrifugum*, currently under investigation for the topical treatment of acne vulgaris. The extract's efficacy is attributed to a synergistic combination of bioactive compounds, including xanthones (such as psorospermin and garcinone E), mangiferin, and betulinic acid. Its primary mechanism involves the inhibition of microbial lipases, which prevents the hydrolysis of sebum triglycerides into irritating free fatty acids. Additionally, the extract demonstrates potent antibacterial activity against *Cutibacterium acnes*, alongside anti-inflammatory, antioxidant, and keratolytic properties that address multiple stages of acne pathogenesis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on psorospermum febrifugum extract.